Accumulating evidences have indicated that NSD2 also functions as an oncogene in several solid tumors, such as lung, colorectal, renal, cervical, prostate cancer, hepatocellular carcinoma, and osteosarcoma (11–17). The gene discussed is NSD2; the disease is prostate carcinoma.